What is Strand Life Sciences Pvt?
Strand Life Sciences Pvt is a prominent player in the genomics and precision medicine sector, offering a comprehensive suite of services including Next-Generation Sequencing (NGS) and PCR diagnostics. With over two and a half decades of experience, the company excels in pharma and biomarker discovery, alongside the development of sophisticated genomics software applications. Their innovative platform integrates AI and real-world data to enhance the analysis and reporting of oncological data, serving a global clientele across the pharmaceutical, biotechnology, and academic research fields. The company's commitment to leveraging clinical and omics data underscores its role in advancing personalized healthcare solutions.
How much funding has Strand Life Sciences Pvt raised?
Strand Life Sciences Pvt has raised a total of $27.6M across 3 funding rounds:
Series A
$4.6M
Series B
$10M
Private Equity
$13M
Series A (2002): $4.6M with participation from Steamboat Ventures
Series B (2013): $10M, investors not publicly disclosed
Private Equity (2018): $13M supported by Quadria Capital Investment Management and HealthQuad
Key Investors in Strand Life Sciences Pvt
Steamboat Ventures
Steamboat Ventures is an investment firm focused on helping young companies become market leaders, investing in early to growth stage companies within the technology, media, and consumer sectors. They are dedicated to creating lasting value in each of its investments.
Quadria Capital Investment Management
Quadria Capital is a leading private equity firm focused on transforming healthcare in Asia through strategic investments in scalable healthcare companies. The firm emphasizes partnerships with organizations that have strong management teams and clear market differentiation.
HealthQuad
HealthQuad is India's leading healthcare innovation fund focused on nurturing innovative models that transform healthcare and create an inclusive impact on communities. The company invests across the healthcare value chain, emphasizing disease prevention, quality of care, and leveraging technology to improve business models.
What's next for Strand Life Sciences Pvt?
The substantial enterprise-level funding and recent strategic investment indicate Strand Life Sciences Pvt is poised for significant expansion and further innovation. This capital infusion is likely to fuel advancements in their AI-driven genomics platform, potentially broadening their service offerings in precision medicine and oncology. The company's focus on integrating diverse data streams suggests a strategic push towards more comprehensive diagnostic and therapeutic solutions, reinforcing their position in the competitive biotechnology landscape. Future growth may involve scaling operations, enhancing global market penetration, and forging new partnerships to accelerate the development and deployment of their cutting-edge genomics technologies.
See full Strand Life Sciences Pvt company page
